DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Loews Sapphire Falls Resort

2019年3月18日 (月) 午前 11:00 - 2019年3月20日 (水) 午後 1:30

6601 Adventure Way,, Orlando, FL 32819

Medical Affairs and Scientific Communications Forum

3 Meetings, 1 Location: Medical Communications, Medical Science Liaisons, Medical Writing

Session 5 Track 2: EU GDPR and Medical Writing

Session Chair(s)

Andrea Tuttle Meyers

Andrea Tuttle Meyers

Senior Vice President, Clinical Operations

Syneos Health, United States

The General Data Protection Regulation (GDPR) became enforceable in the European Union in May 2018. A panel discussion will explore the impact of the EU GDPR as it relates to clinical trials, specifically with regard to the impact on the production of clinical trial documents prepared by medical writers. The session will explore the changes and the challenges of implementing the EU GDPR in clinical trial documents with input from clinical trial industry leaders. It will also look at how this has impacted the pharmacovigilance system in the UK and how the MHRA have adapted their data collection systems. MHRA will also provide an update on Brexit.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe and discuss the EU GDPR changes that went into effect May 2018
  • Apply the EU GDPR during the preparation of clinical trial documents, particularly the informed consent
  • Disclose clinical trial data, using anonymization techniques compliant with the EU GDPR

Speaker(s)

Larry  Singer, JD, MBA, RPh

Speaker

Larry Singer, JD, MBA, RPh

Syneos Health, Inc., United States

Senior Corporate Counsel & Deputy Global Data Protection Officer

Lisa  Zimmerman, MS

Speaker

Lisa Zimmerman, MS

Axis Pharma, United States

President

Mick  Foy

Speaker

Mick Foy

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Director of Delivery

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。